BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21298609)

  • 1. [Beyond microbiota: genetic factors in post-infectious irritable bowel syndrome].
    Felber J; Stallmach A
    Z Gastroenterol; 2011 Feb; 49(2):234-6. PubMed ID: 21298609
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis.
    Villani AC; Lemire M; Thabane M; Belisle A; Geneau G; Garg AX; Clark WF; Moayyedi P; Collins SM; Franchimont D; Marshall JK
    Gastroenterology; 2010 Apr; 138(4):1502-13. PubMed ID: 20044998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postinfectious irritable bowel syndrome: a genetic link identified?
    Vermeire S; Van Assche G; Rutgeerts P
    Gastroenterology; 2010 Apr; 138(4):1246-9. PubMed ID: 20188132
    [No Abstract]   [Full Text] [Related]  

  • 4. Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario.
    Marshall JK; Thabane M; Garg AX; Clark W; Meddings J; Collins SM;
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1317-22. PubMed ID: 15606393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Post-infectious IBS].
    Kamikozuru K; Matsumoto T; Miwa H
    Nihon Rinsho; 2006 Aug; 64(8):1544-8. PubMed ID: 16898630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To "lump" or to "split" the functional somatic syndromes: can infectious and emotional risk factors differentiate between the onset of chronic fatigue syndrome and irritable bowel syndrome?
    Moss-Morris R; Spence M
    Psychosom Med; 2006; 68(3):463-9. PubMed ID: 16738080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome.
    van der Veek PP; van den Berg M; de Kroon YE; Verspaget HW; Masclee AA
    Am J Gastroenterol; 2005 Nov; 100(11):2510-6. PubMed ID: 16279907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Irritable bowel syndrome: novel views on the epidemiology and potential risk factors.
    Rey E; Talley NJ
    Dig Liver Dis; 2009 Nov; 41(11):772-80. PubMed ID: 19665952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease burden of post-infectious irritable bowel syndrome in The Netherlands.
    Haagsma JA; Siersema PD; De Wit NJ; Havelaar AH
    Epidemiol Infect; 2010 Nov; 138(11):1650-6. PubMed ID: 20223049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-infectious irritable bowel syndrome in patients with Shigella infection.
    Ji S; Park H; Lee D; Song YK; Choi JP; Lee SI
    J Gastroenterol Hepatol; 2005 Mar; 20(3):381-6. PubMed ID: 15740480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: consensus issues.
    Cuomo R; Savarese MF; Gargano R
    Dig Dis; 2007; 25(3):241-4. PubMed ID: 17827948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genes and environment in irritable bowel syndrome: one step forward.
    Talley NJ
    Gut; 2006 Dec; 55(12):1694-6. PubMed ID: 17124153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a risk score for post-infectious irritable bowel syndrome.
    Thabane M; Simunovic M; Akhtar-Danesh N; Marshall JK
    Am J Gastroenterol; 2009 Sep; 104(9):2267-74. PubMed ID: 19568228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenesis of irritable bowel syndrome are genes a SERT-ainty?
    Talley NJ
    J Clin Gastroenterol; 2009; 43(10):902-4. PubMed ID: 19727006
    [No Abstract]   [Full Text] [Related]  

  • 15. Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Corinaldesi R
    Dig Dis; 2007; 25(3):245-8. PubMed ID: 17827949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postinfectious irritable bowel syndrome--a meta-analysis.
    Halvorson HA; Schlett CD; Riddle MS
    Am J Gastroenterol; 2006 Aug; 101(8):1894-9; quiz 1942. PubMed ID: 16928253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome.
    Jarrett ME; Kohen R; Cain KC; Burr RL; Poppe A; Navaja GP; Heitkemper MM
    Biol Res Nurs; 2007 Oct; 9(2):161-9. PubMed ID: 17909168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery.
    Marshall JK; Thabane M; Garg AX; Clark WF; Moayyedi P; Collins SM;
    Gut; 2010 May; 59(5):605-11. PubMed ID: 20427395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study identifies two novel genomic regions in irritable bowel syndrome.
    Holliday EG; Attia J; Hancock S; Koloski N; McEvoy M; Peel R; D'Amato M; Agréus L; Nyhlin H; Andreasson A; Almazar AE; Saito YA; Scott RJ; Talley NJ
    Am J Gastroenterol; 2014 May; 109(5):770-2. PubMed ID: 24797007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.